DepressionResearchNovember 13, 2026
One Dose After Delivery: A Trial of Esketamine to Prevent Postpartum Depression
A 2024 trial in The BMJ gave new mothers with prenatal depressive symptoms a single low dose of esketamine after childbirth. Major depression at six weeks fell from about 25% to under 7%.
